简介: 【摘要】 目的 评价不同他汀类药物治疗早发冠心病急性心肌梗死的近期临床疗效。方法 100例早发冠心病急性心肌梗死患者, 根据治疗药物不同分为观察组与对照组, 各 50例。两组均采用常规治疗, 此外对照组给予瑞舒伐他汀治疗, 观察组给予阿托伐他汀治疗。治疗前及治疗结束后即对两组甘油三酯、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、总胆固醇水平进行检测比较, 并观察不良反应发生情况。结果 治疗前, 两组甘油三酯、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇和总胆固醇水平比较差异无统计学意义( P>0.05) ;治疗后, 观察组的甘油三酯水平( 1.65±1.32) mmol/L、低密度脂蛋白胆固醇水平( 3.70±0.68) mmol/L、高密度脂蛋白胆固醇水平( 1.87±1.15) mmol/L、总胆固醇水平( 5.61±0.99) mmol/L均优于对照组的( 2.43±1.86)、( 4.11±0.70)、( 1.46±0.73)、( 6.32±1.94) mmol/L, 差异均具有统计学意义( P<0.05)。观察组不良反应发生率 8.00%显著低于对照组的 28.00%, 差异具有统计学意义( P<0.05)。结论 相较瑞舒伐他汀, 阿托伐他汀对早发冠心病急性心肌梗死患者的治疗更为优异。 【关键词】 他汀类药物 ;早发冠心病 ;急性心肌梗死 ;临床疗效 [Abstract] Objective To evaluate the short-term clinical efficacy of different statins in the treatment of acute myocardial infarction of early coronary heart disease. Methods 100 patients with acute myocardial infarction of early coronary heart disease were divided into observation group and control group according to different drugs, 50 cases in each group. In addition, the control group was treated with rosuvastatin, and the observation group was treated with atorvastatin. Before and after treatment, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and total cholesterol were detected and compared between the two groups, and adverse reactions were observed. Results before the treatment, there was no significant difference in the levels of TG, LDL-C, HDL-C and TC between the two groups (P > 0.05); after the treatment, the levels of TG (1.65 ± 1.32) mmol / L, LDL-C (3.70 ± 0.68) mmol / L, HDL-C (1.87 ± 1.15) mmol / L and TC in the observation group The level of cholesterol (5.61 ± 0.99) mmol / l was significantly higher than that of the control group (2.43 ± 1.86), (4.11 ± 0.70), (1.46 ± 0.73), (6.32 ± 1.94) mmol / L (P < 0.05). The incidence of adverse reactions in the observation group was 8.00%, which was significantly lower than that in the control group (28.00%) (P < 0.05). Conclusion compared with rosuvastatin, atorvastatin is superior in the treatment of early-onset acute myocardial infarction.
简介:摘要目的探讨化疗栓塞联合射频消融治疗肝癌的近期效果。方法选取2009年3月至2013年9月夏邑县人民医院收治的58例肝癌患者,按照治疗方法分为观察组(化疗栓塞联合射频消融,30例)和对照组(单纯化疗栓塞,28例),比较两组患者近期治疗效果。结果治疗后,对照组血清AFP含量为(274.12±37.61)ng/ml,观察组血清AFP含量为(57.08±21.35)ng/ml,两组差异具有统计学意义(P<0.05)。
简介:摘要目的对比机器人与传统腹腔镜行胰体尾切除术在近期临床疗效上的优劣。方法系统检索PubMed、Embase、Cochrane library、万方数据库、中国知网,收集对比机器人组与传统腹腔镜组胰体尾切除术近期临床疗效的文献。观察指标包括手术时间、术中输血率、保脾率、保脾血管率、中转开腹率、术后并发症发生率、术后严重并发症发生率、胰漏率、严重胰漏率、住院时间等。采用RevMan5.3软件进行Meta分析。结果共纳入11篇非随机对照研究,共计791例患者。Meta分析结果表明,机器人组相比于传统腹腔镜组保脾率高,差异具有统计学意义(OR=2.32,95%CI:1.07~5.04,P=0.03);保脾血管率高,差异具有统计学意义(OR=3.07,95%CI:1.10~8.57,P=0.03);中转开腹率低,差异具有统计学意义(OR=0.58,95%CI:0.35~0.97,P=0.04);住院时间短,差异具有统计学意义(MD=-2.42,95%CI:-4.30~-0.55, P=0.01);手术时间长,差异具有统计学意义(MD=27.11,95%CI:9.06~45.16,P<0.01)。但术后并发症发生率、术后严重并发症发生率、胰漏率、严重胰漏率及术中输血率等结局指标差异无统计学意义。结论机器人胰体尾切除术在近期疗效上显现了一定程度上的优势,值得在有条件的大型医疗中心推广,关于2种术式在远期疗效上的比较还需要进一步的随访研究。